Please login to the form below

Not currently logged in
Email:
Password:

EMA names head of comms team

Marie-Agnes Heine joins regulator from World Health Organization
Marie-Agnes-Heine-EMAThe European Medicines Agency (EMA) has appointed Marie-Agnes Heine as head of its communications department.

Heine (pictured), who has spent 20 years in media positions, will lead communications efforts at an important time for the EU drugs regulator as it looks to push through new legislation on access to clinical trial data.

In her most recent position Heine was a communications officer at the World Health Organization (WHO) where she developed and implemented targeted communications strategies on important pubic health issues.

Heine's career also includes media and communications roles at the United Nations, International Organization for Migration, UN Commission on Information and Accountability for Women's and Children's Health.

The EMA also announced the appointment of Manuel Ortigão as head of human resources. Ortigão, who joined the Agency on August 18, was most recently research manager at the European Foundation for the Improvement of Living and Working Conditions (Eurofound),

He has worked in Portugal, Spain, the UK and Saudi Arabia and held senior human resources roles at companies such as Hewlett-Packard, Unisys and PricewaterhouseCoopers.

3rd September 2014

From: Marketing, Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics